CCI clears Apollo Hospitals Rs 1,254 crore buyout of IFC stake in AHLL

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

APOLLOHOSP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹6845.00

prior close

₹6878.50

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.6%-1.2% vs market

Hospital peers, median of 23sector-0.6%+0.0% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty 100 and in line with its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.6

15m

-0.2

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6+0.6-1.2-0.6+0.0

Next day

-0.5-0.5+0.0-2.1+1.7

-0.4+0.0-0.4-1.8+1.5

+0.4+0.9-0.5-1.1+1.5

-0.5+1.2-1.8-2.8+2.3

+1.5+0.8+0.8-1.0+2.5

+3.2+2.4+0.8+0.6+2.6

15d

+9.9+1.5+8.4+2.6+7.3

+12.5+2.5+9.9+2.9+9.6

+4.1-10.1+14.2-6.0+10.1

+11.4-1.4+12.9+5.2+6.2

UpDownMarket · Nifty 100Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Competition Commission of India has approved Apollo Hospitals acquisition of 30.58 percent stake (4.16 crore shares) held jointly by International Finance Corporation and IFC EAF in its subsidiary Apollo Health and Lifestyle Limited. The deal is worth Rs 1,254.07 crore and was first cleared by Apollos board on September 12, 2025, subject to regulator approval. With this green light, Apollo moves closer to consolidating full ownership of its healthcare services subsidiary.

Likely market impact

CCI approval removes a key hurdle. Full control of AHLL strengthens Apollos grip on its diagnostics and wellness arm, a positive for long-term investors.